{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:31:52Z","timestamp":1790065912740,"version":"4.0.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T00:00:00Z","timestamp":1574035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Women's Dermatology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ijwd.2019.11.004","type":"journal-article","created":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T07:04:46Z","timestamp":1577430286000},"page":"80-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["A concise clinician\u2019s guide to therapy for hidradenitis suppurativa"],"prefix":"10.1097","volume":"6","author":[{"given":"Emily","family":"Nesbitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Clements","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia","family":"Driscoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"5","key":"10.1016\/j.ijwd.2019.11.004_b0005","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/archdermatol.2010.72","article-title":"Treatment of hidradenitis suppurativa with etanercept injection","volume":"146","author":"Adams","year":"2010","journal-title":"Arch Dermatol"},{"issue":"5 Suppl 1","key":"10.1016\/j.ijwd.2019.11.004_b0010","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.jaad.2015.07.049","article-title":"Scientific evidence for the use of current traditional systemic therapies in patients with hidradenitis suppurativa","volume":"73","author":"Alhusayen","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"47","key":"10.1016\/j.ijwd.2019.11.004_b0015","doi-asserted-by":"crossref","first-page":"13205","DOI":"10.3748\/wjg.v21.i47.13205","article-title":"Safety of anti-tumor necrosis factor therapy during pregnancy in patients with inflammatory bowel disease","volume":"21","author":"Androulakis","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.ijwd.2019.11.004_b0025","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/bjd.14338","article-title":"Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum","volume":"174","author":"Blok","year":"2016","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.ijwd.2019.11.004_b0030","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000100883","article-title":"Hidradenitis suppurativa and zinc: a new therapeutic approach. A pilot study","volume":"214","author":"Brocard","year":"2007","journal-title":"Dermatology"},{"issue":"5","key":"10.1016\/j.ijwd.2019.11.004_b0040","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jaad.2018.11.035","article-title":"Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: clinical and ultrasound observations","volume":"80","author":"Caposiena Caro","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.ijwd.2019.11.004_b0045","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-4362.1983.tb02150.x","article-title":"Topical treatment of hidradenitis suppurativa with clindamycin","volume":"22","author":"Clemmensen","year":"1983","journal-title":"Int J Dermatol"},{"issue":"5 Suppl 1","key":"10.1016\/j.ijwd.2019.11.004_b0050","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/j.jaad.2015.07.043","article-title":"New and traditional surgical approaches to hidradenitis suppurativa","volume":"73","author":"Danby","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.ijwd.2019.11.004_b0055","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/archderm.1972.01620080011005","article-title":"Phototoxic potential of minocycline and doxycycline","volume":"105","author":"Frost","year":"1972","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.ijwd.2019.11.004_b0060","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000228334","article-title":"Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients","volume":"219","author":"Gener","year":"2009","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.ijwd.2019.11.004_b0065","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jaad.2018.06.063","article-title":"Antiandrogen therapy with spironolactone for the treatment of hidradenitis suppurativa","volume":"80","author":"Golbari","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.ijwd.2019.11.004_b0070","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaad.2009.06.050","article-title":"Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial","volume":"62","author":"Grant","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"5 Suppl 1","key":"10.1016\/j.ijwd.2019.11.004_b0080","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.jaad.2015.07.050","article-title":"Laser and light-based treatment options for hidradenitis suppurativa","volume":"73","author":"Hamzavi","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijwd.2019.11.004_b0085","series-title":"Dermatologic surgery","first-page":"729","article-title":"Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus: surgical approach","author":"Hurley","year":"1989"},{"issue":"5","key":"10.1016\/j.ijwd.2019.11.004_b0100","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa1504370","article-title":"Two phase 3 trials of adalimumab for hidradenitis suppurativa","volume":"375","author":"Kimball","year":"2016","journal-title":"New Engl J Med"},{"issue":"4","key":"10.1016\/j.ijwd.2019.11.004_b0105","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2310\/7750.2007.00019","article-title":"Hidradenitis suppurativa in 64 female patients: retrospective study comparing oral antibiotics and antiandrogen therapy","volume":"11","author":"Kraft","year":"2007","journal-title":"J Cutan Med Surg"},{"issue":"5 Suppl 1","key":"10.1016\/j.ijwd.2019.11.004_b0110","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/j.jaad.2015.07.053","article-title":"Treatment of hidradenitis suppurativa with biologic medications","volume":"73","author":"Lee","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijwd.2019.11.004_b0115","series-title":"Hidradenitis suppurativa \u2013 a disease primer","author":"Lockwood","year":"2017"},{"issue":"1","key":"10.1016\/j.ijwd.2019.11.004_b0120","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/bjd.12884","article-title":"Acitretin treatment for hidradenitis suppurativa: a prospective series of 17 patients","volume":"171","author":"Matusiak","year":"2014","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.ijwd.2019.11.004_b0125","doi-asserted-by":"crossref","first-page":"240","DOI":"10.7150\/ijms.7.240","article-title":"Surgical management of hidradenitis suppurativa","volume":"7","author":"Menderes","year":"2010","journal-title":"Int J Med Sci"},{"issue":"2","key":"10.1016\/j.ijwd.2019.11.004_b0130","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/DSS.0000000000000264","article-title":"Recurrence rate and patient satisfaction of CO2 laser evaporation of lesions in patients with hidradenitis suppurativa: a retrospective study","volume":"41","author":"Mikkelsen","year":"2015","journal-title":"Dermatol Surg"},{"issue":"3","key":"10.1016\/j.ijwd.2019.11.004_b0135","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2133.1986.tb05740.x","article-title":"A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa","volume":"115","author":"Mortimer","year":"1986","journal-title":"Br J Dermatol"},{"issue":"1\u20133","key":"10.1016\/j.ijwd.2019.11.004_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2011.08.047","article-title":"Pathogenesis and pharmacotherapy of hidradenitis suppurativa","volume":"672","author":"Nazary","year":"2011","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.ijwd.2019.11.004_b0145","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jaad.2017.07.008","article-title":"Topical 15% resorcinol for hidradenitis suppurativa: an uncontrolled prospective trial with clinical and ultrasonographic follow-up","volume":"77","author":"Pascual","year":"2017","journal-title":"J Am Acad Dermat"},{"issue":"5","key":"10.1016\/j.ijwd.2019.11.004_b9000","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jaad.2016.10.032","article-title":"Management of hidradenitis suppurativa in pregnancy","volume":"76","author":"Perng","year":"2017","journal-title":"J Am Acad Dermat"},{"issue":"6","key":"10.1016\/j.ijwd.2019.11.004_b0150","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jaad.2016.06.049","article-title":"Intralesional triamcinolone for flares of hidradenitis suppurativa (HS): a case series","volume":"75","author":"Riis","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.ijwd.2019.11.004_b0165","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jaad.2009.08.001","article-title":"Hidradenitis suppurativa and smoking","volume":"62","author":"Simonart","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"3 Suppl","key":"10.1016\/j.ijwd.2019.11.004_b0170","doi-asserted-by":"crossref","first-page":"10S","DOI":"10.1378\/chest.86.3.10S","article-title":"Pregnancy and tuberculosis","volume":"86","author":"Snider","year":"1984","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ijwd.2019.11.004_b0175","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000182261","article-title":"Absence of efficacy of oral isotretinoin in hidradenitis suppurativa: a retrospective study based on patients' outcome assessment","volume":"218","author":"Soria","year":"2009","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.ijwd.2019.11.004_b0185","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/jamadermatol.2015.3903","article-title":"Safety and efficacy of anakinra in severe hidradenitis suppurativa: a randomized clinical trial","volume":"152","author":"Tzanetakou","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.ijwd.2019.11.004_b0190","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3109\/09546634.2011.571657","article-title":"Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa","volume":"23","author":"van Rappard","year":"2012","journal-title":"J Dermatolog Treat"},{"issue":"3","key":"10.1016\/j.ijwd.2019.11.004_b0195","first-page":"115","article-title":"Tetracycline induced discoloration of deciduous teeth: case series","volume":"6","author":"Vennila","year":"2014","journal-title":"J Int Oral Health"},{"issue":"9","key":"10.1016\/j.ijwd.2019.11.004_b0200","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.1468-3083.2012.04668.x","article-title":"Metformin for the treatment of hidradenitis suppurativa: a little help along the way","volume":"27","author":"Verdolini","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.ijwd.2019.11.004_b0205","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/art.24462","article-title":"Biologic therapy and pregnancy outcomes in women with rheumatic diseases","volume":"61","author":"Vinet","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.ijwd.2019.11.004_b0210","first-page":"17","article-title":"Hidradenitis suppurativa: causes, features, and current treatments","volume":"11","author":"Vinkel","year":"2018","journal-title":"J Clin Aesthet Dermatol"},{"issue":"10","key":"10.1016\/j.ijwd.2019.11.004_b0215","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.dld.2013.02.001","article-title":"Update on pregnancy and breastfeeding in the era of biologics","volume":"45","author":"Yarur","year":"2013","journal-title":"Dig Liver Dis"},{"issue":"4","key":"10.1016\/j.ijwd.2019.11.004_b0220","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000329023","article-title":"Dapsone therapy for hidradenitis suppurativa: a series of 24 patients","volume":"222","author":"Yazdanyar","year":"2011","journal-title":"Dermatology"}],"container-title":["International Journal of Women's Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352647519301224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352647519301224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T14:27:31Z","timestamp":1641565651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352647519301224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S2352647519301224"],"URL":"https:\/\/doi.org\/10.1016\/j.ijwd.2019.11.004","relation":{},"ISSN":["2352-6475"],"issn-type":[{"value":"2352-6475","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A concise clinician\u2019s guide to therapy for hidradenitis suppurativa","name":"articletitle","label":"Article Title"},{"value":"International Journal of Women's Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijwd.2019.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Inc. on behalf of Women's Dermatologic Society.","name":"copyright","label":"Copyright"}]}}